Cas9 Stable Cell Line for CRISPR (Human pancreatic carcinoma MIA PaCa-2, inducible)

Model: CLHKCAS913
Availability: In Stock
Price: $999.00
Qty:  
   - OR -   

Introduction

 

CRISPR, the Clustered Regularly Interspaced Short Palindromic Repeats, is currently the most commonly used technology for genome editing. There are two distinct components in this system: a guide RNA and an RNA-guided DNA nuclease, Cas9 (CRISPR associated protein 9). When these two components are expressed together in the same cells, the genomic sequence targeted by the gRNA will be edited (modified or permanently disrupted).

 

Given the immediate availability of mouse and human lentiviral CRISPR gRNA libraries, CRISPR technology has tremendously benefitted the scientific community in both academia and industry. PrimCells now is providing tetracycline inducible Cas9 expressing cell lines of a variety of tissue origin to further facilitate high-throughput, CRISPR based genome-wide screening. This cell line is G418 resistant and tetracycline inducible.

 

 

Click here to download PDF datasheet

Write a review

Your Name:


Your Review: Note: HTML is not translated!

Rating: Bad           Good

Enter the code in the box below:



PrimCells, LLC | Your Primary Cell Solution © 2017 All Rights Reserved. | Developed by Boson Technologies Inc.